Engineers Gate Manager LP Regeneron Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

  • $3.68 Billion
  • Q1 2024

A detailed history of Engineers Gate Manager LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 5,935 shares of REGN stock, worth $6.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,935
Previous 873 579.84%
Holding current value
$6.2 Million
Previous $766,000 645.69%
% of portfolio
0.16%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $4.57 Million - $5.03 Million
5,062 Added 579.84%
5,935 $5.71 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $240,305 - $273,327
310 Added 55.06%
873 $766,000
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $2.4 Million - $2.93 Million
-3,466 Reduced 86.03%
563 $463,000
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $726,631 - $861,903
1,038 Added 34.7%
4,029 $2.89 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $2.04 Million - $2.47 Million
2,991 New
2,991 $2.46 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $1.14 Million - $1.44 Million
-1,986 Reduced 78.62%
540 $372,000
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $545,608 - $735,145
995 Added 64.99%
2,526 $1.49 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $149,970 - $176,004
-252 Reduced 14.13%
1,531 $1.07 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $969,024 - $1.2 Million
1,783 New
1,783 $1.13 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $777,236 - $922,019
-1,354 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $640,171 - $756,263
1,354 New
1,354 $756,000
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $943,940 - $1.16 Million
-2,113 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $1.51 Million - $1.92 Million
-3,150 Reduced 59.85%
2,113 $1.02 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $2.87 Million - $3.46 Million
5,263 New
5,263 $2.95 Million
Q2 2020

Aug 17, 2020
SELL
$493.32 - $643.92 $1.26 Million - $1.65 Million
-2,558 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $5.69 Million - $8.37 Million
-16,935 Reduced 86.88%
2,558 $1.25 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $4.93 Million - $6.78 Million
17,995 Added 1201.27%
19,493 $7.32 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $153,137 - $178,298
-560 Reduced 27.21%
1,498 $416,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $406,856 - $563,325
1,358 Added 194.0%
2,058 $644,000
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $260,456 - $307,699
700 New
700 $287,000

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email